TrialAlzheimer's & dementia : the journal of the Alzheimer's Association2025

TRAILBLAZER-ALZ 4: A phase 3 trial comparing donanemab with aducanumab on amyloid plaque clearance in early, symptomatic Alzheimer's disease.

Stephen Salloway et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.